These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 26173861

  • 21. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R, Sabino J, Gee M, Bouchard T, Fisher N, Hanstock C, Emery D, Martin WR.
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [Abstract] [Full Text] [Related]

  • 22. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.
    J Neurol Sci; 2014 Dec 15; 347(1-2):210-3. PubMed ID: 25451006
    [Abstract] [Full Text] [Related]

  • 23. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R, García-García D, Clavero P, Gasca-Salas C, García-Eulate R, Zubieta JL, Arbizu J, Obeso JA, Rodríguez-Oroz MC.
    Brain; 2014 Aug 15; 137(Pt 8):2356-67. PubMed ID: 24951642
    [Abstract] [Full Text] [Related]

  • 24. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M, Kunz MS, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R, Hilker-Roggendorf R, LANDSCAPE Consortium, Berg D, Kalbe E, Braak H, Del Tredici K, Baudrexel S, Huppertz HJ, Kassubek J.
    Hum Brain Mapp; 2020 Apr 15; 41(6):1416-1434. PubMed ID: 31789477
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson's disease with mild cognitive impairment.
    Brandão PR, Pereira DA, Grippe TC, Bispo DDC, Maluf FB, Titze-de-Almeida R, de Almeida E Castro BM, Munhoz RP, Tavares MCH, Cardoso F.
    Front Neuroanat; 2024 Apr 15; 18():1362165. PubMed ID: 39206076
    [Abstract] [Full Text] [Related]

  • 27. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O'Brien JT, Brooks DJ, Burn DJ, ICICLE-PD study group, Barker RA.
    Brain; 2014 Oct 15; 137(Pt 10):2743-58. PubMed ID: 25080285
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment.
    Zhou C, Guan XJ, Guo T, Zeng QL, Gao T, Huang PY, Xuan M, Gu QQ, Xu XJ, Zhang MM.
    CNS Neurosci Ther; 2020 Jan 15; 26(1):117-125. PubMed ID: 31278861
    [Abstract] [Full Text] [Related]

  • 30. Progression of cortical thinning in early Parkinson's disease.
    Ibarretxe-Bilbao N, Junque C, Segura B, Baggio HC, Marti MJ, Valldeoriola F, Bargallo N, Tolosa E.
    Mov Disord; 2012 Dec 15; 27(14):1746-53. PubMed ID: 23124622
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.
    Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LC, Kandiah N.
    Neuroimage Clin; 2017 Dec 15; 14():37-42. PubMed ID: 28116240
    [Abstract] [Full Text] [Related]

  • 35. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
    Danti S, Toschi N, Diciotti S, Tessa C, Poletti M, Del Dotto P, Lucetti C.
    Eur J Neurol; 2015 Dec 15; 22(12):1564-72. PubMed ID: 26212370
    [Abstract] [Full Text] [Related]

  • 36. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
    Cicero CE, Donzuso G, Luca A, Davì M, Baschi R, Mostile G, Giuliano L, Palmucci S, Salerno A, Monastero R, Nicoletti A, Zappia M.
    Eur J Neurol; 2022 Nov 15; 29(11):3197-3204. PubMed ID: 35790057
    [Abstract] [Full Text] [Related]

  • 37. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
    Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM.
    Lancet Neurol; 2017 Jan 15; 16(1):66-75. PubMed ID: 27866858
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Imaging changes associated with cognitive abnormalities in Parkinson's disease.
    Koshimori Y, Segura B, Christopher L, Lobaugh N, Duff-Canning S, Mizrahi R, Hamani C, Lang AE, Aminian K, Houle S, Strafella AP.
    Brain Struct Funct; 2015 Jul 15; 220(4):2249-61. PubMed ID: 24816399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.